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Complications in vascular and endovascular surgery,
part I
Alain Branchereau, Michael Jacobs; Armonk, NY; 2001;
Futura; 283 pages; $125.00.
Writings solely devoted to examining complications after vas-
cular and endovascular procedures are long overdue. Lagging
behind the rapid development of new technology for operative
and, more recently, endoluminal therapy of peripheral vascular
disease, has been the constructive approach to the prevention and
treatment of complications unique to these patients. By far,
patients with atherosclerotic occlusive disease of the peripheral
arterial tree are among the most susceptible to devastating com-
plications caused by advanced age, risk factors, multiple comor-
bidities, and occult multiorgan involvement. Branchereau and
Jacobs have compiled the expertise of many surgeons, of which
the large majority are European, to “understand the mechanism,
discern preventative measures, determine causative factors and
thereby master and improve future procedures.” The book
emerges from the Annual European Vascular Course and repre-
sents the first of two parts. Part I encompasses 29 chapters cover-
ing such topics as general concepts surrounding complications,
mechanisms of myointimal hyperplasia and hypercoagulability,
graft infections, vascular access, and cerebrovascular disease. Part
II (not yet published) will examine complications related to such
topics as aortic aneurysm and lower limb ischemia.
As with other textbooks that arise from a clinical course or
scientific meeting, the chapters are focused but somewhat imbal-
anced. For example, the first chapter examines the relationship of
complications to the benefits of treatment. Knowledge of terms
such as “absolute risk reduction” and “number needed to treat”
is essential to a vascular surgeon and well defined in the book.
Lacking in the text are other important topics related to compli-
cations, such as outcomes measurement, decision analysis, the use
of critical pathways, and the prevention of medical errors. All of
these topics remain central to the prevention of complications.
Another example of the need for more information can be seen in
the chapter on cardiac risk in the vascular patient. The chapter is
at best superficial, given the amount of information published on
the topic. Moreover, a detailed overview of how to treat myocar-
dial ischemia and infarction during the perioperative period
would make the chapter unique and appropriate for the book.
Although a chapter devoted to the prevention of myointimal
hyperplasia informs well about the drugs used for the problem,
few guidelines are given as to the treatment for the problem after
discovery. Perhaps bypass graft duplex surveillance and optimal
treatment of this complication will be addressed in part II of this
textbook series.
Six chapters are devoted to different aspects of complications
as related to the treatment of cerebrovascular disease. Here, the
text excels at the combination of conciseness and valuable infor-
mation. The chapter that summarizes complications of percuta-
neous carotid artery angioplasty imparts an outstanding overview
while recognizing the controversy related to the procedure.
Although the technology for this procedure remains in a rapid
state of flux, more information about the indication and use of
stents for this procedure would be helpful.
Ample figures and tables compliment the text and allow the
reader to ascertain a quick reference or a more in-depth analysis.
The lack of an index makes the book difficult to navigate. Given
that the book covers a topic for which an index would be used reg-
ularly, subsequent editions should incorporate this feature.
Nevertheless, this textbook is one of the first to examine compli-
cations surrounding vascular and endovascular procedures, and
vascular surgeons would be wise to add it to their arm-length
information armamentarium. Publication of part II from the next
European Vascular Course will complete and strengthen the series.
Robert B. McLafferty, MD
Springfield, Ill
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Managing oral anticoagulation therapy: Clinical and
operational guidelines
Jack E. Ansell, Lynn B. Oertel, Ann K. Wittkowsky;
Gaithersburg, MD; 2000; Aspen; $229.00.
The book by Ansell et al is a unique collection of articles deal-
ing with the topic of oral anticoagulants. It is in the form of a
binder with removable sections that can be updated. It is divided
into two main parts—the first part (A) concentrates on practical
issues involved in setting up and running an anticoagulation ser-
vice. All aspects including medical and nonmedical issues are dis-
cussed, including quality assurance, reimbursement, risk
management, and even setting up a business plan. The second part
(B) includes more traditional discussions on topics such as throm-
bogenesis, management of thromboembolism, anticoagulants,
venous thromboembolism prophylaxis, etc. In general, the chapters
are concise, thorough, and nicely illustrated, and they read well.
The author list is extensive and full of many experts in the area.
The target audience for this book is primarily those involved
in setting up and running oral anticoagulation clinics. As such, it
is not a manual that is needed by most practicing vascular sur-
geons or even physicians practicing vascular medicine. However,
for those physicians charged with the administration of oral anti-
coagulation clinics, this manual is a very good reference. It is
especially valuable for those who may be setting up such a pro-
gram. It should also be a useful resource for nurses involved in
anticoagulation management and nonphysician medical assistants
as well. Its practical nature makes it a valued contribution in the
field, and the fact that it is able to be updated should allow it to
remain current. As stated by the authors in the Preface, “Because
it is in a format that allows for routine updating, the text will
remain contemporary and useful for many years to come.” I
would certainly agree with this assessment.
Thomas Wakefield, MD
University of Michigan Medical Center
Ann Arbor, Mich
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Cardiovascular pathology, 3rd edition
Malco D. Silver, Avrum I. Gotlieb, Frederick J. Schoen;
Philadelphia, Pa; 2001; Churchill Livingstone; 808 pages;
$295.00.
Cardiovascular disease and complications from therapeutic
interventions in the cardiovascular tree remain the number one
cause for morbidity and mortality in developed countries.
Cardiovascular pathology, 3rd edition by Malco D. Silver, MD,
Avrum I. Gotlieb, MD, and Frederick J. Schoen, MD, PhD, is a
significant revision of Dr Silver’s original book of 1983 and 1991
and is the authoritative reference for understanding the state of
the art in cardiovascular pathology.
This 808-page book contains 24 chapters by 30 international
experts in cardiovascular pathology. The basic outline of the origi-
nal text is maintained, starting with examination of the heart and
microscopy of cardiac and peripheral vascular structures. Age-
related changes is followed by four chapters covering diseases of
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